Bank of Montreal
ADPT icon

Bank of Montreal’s Adaptive Biotechnologies ADPT Stock Holding History

Bank of Montreal’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
11,411
+659
+6% +$10.1K ﹤0.01% 2888
2026
Q1 		$149K Sell
10,752
-18,807
-64% -$300K ﹤0.01% 3026
2025
Q4 		$480K Buy
29,559
+329
+1% +$5.37K ﹤0.01% 2326
2025
Q3 		$437K Sell
29,230
-54
-0.2% -$658 ﹤0.01% 2328
2025
Q2 		$341K Sell
29,284
-2,624
-8% -$23.8K ﹤0.01% 2516
2025
Q1 		$237K Buy
31,908
+18,886
+145% +$145K ﹤0.01% 2640
2024
Q4 		$78.1K Sell
13,022
-1
-0% -$6 ﹤0.01% 3010
2024
Q3 		$65.1K Sell
13,023
-280
-2% -$1.22K ﹤0.01% 3353
2024
Q2 		$48.2K Buy
+13,303
New +$42.2K ﹤0.01% 3431
2023
Q2 		– Sell
-12,431
Closed -$111K – 3938
2023
Q1 		$111K Buy
+12,431
New +$110K ﹤0.01% 3217
2022
Q4 		– Sell
-19,145
Closed -$137 – 3930
2022
Q3 		$137 Buy
19,145
+2,612
+16% +$24.6K ﹤0.01% 3353
2022
Q2 		$142 Sell
16,533
-75,913
-82% -$667K ﹤0.01% 3376
2022
Q1 		$1.28M Buy
+92,446
New +$1.45M ﹤0.01% 2182
2021
Q4 		– Sell
-6,661
Closed -$219K – 3471
2021
Q3 		$219K Buy
+6,661
New +$241K ﹤0.01% 3289
2021
Q2 		– Sell
-2,414
Closed -$101K – 3641
2021
Q1 		$101K Buy
2,414
+626
+35% +$33.9K ﹤0.01% 3373
2020
Q4 		$112K Buy
1,788
+491
+38% +$25.3K ﹤0.01% 3524
2020
Q3 		$63K Buy
1,297
+2
+0.2% +$84 ﹤0.01% 3320
2020
Q2 		$62K Sell
1,295
-260
-17% -$9.48K ﹤0.01% 3323
2020
Q1 		$44K Buy
1,555
+1,464
+1,609% +$40.8K ﹤0.01% 2938
2019
Q4 		$3K Buy
+91
New +$2.61K ﹤0.01% 4745

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of Montreal's ADPT Position: Q2 2026 in Review

Bank of Montreal increased its Adaptive Biotechnologies (ADPT) stake by 6.1% in Q2 2026, buying an estimated $10.1K and bringing the position to 11,411 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #2888.

Bank of Montreal first reported a position in ADPT in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.28M in Q1 2022. 280 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Bank of Montreal held 11,411 shares of Adaptive Biotechnologies worth $245K as of Q2 2026.
  • Bank of Montreal bought 659 Adaptive Biotechnologies shares in Q2 2026, an estimated $10.1K.
  • Adaptive Biotechnologies made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2888 holding.
  • Bank of Montreal first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 20 quarters since.
  • Bank of Montreal's Adaptive Biotechnologies position peaked at $1.28M in Q1 2022.
  • 280 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.